NANCY SPALLUTO: Open Payments
NPI 1164126447 · BELLE MEAD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 29 payments from 6 companies in 2025. Trend: 2023 $421 · 2024 $933 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $234 |
| E.R. Squibb & Sons, L.L.C. | 2 | $149 |
| ABBVIE INC. | 6 | $125 |
| Lundbeck LLC | 5 | $95 |
| Teva Pharmaceuticals USA, Inc. | 5 | $88 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: REXULTI, COBENFY, VRAYLAR, UZEDY, ABILIFY MAINTENA, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
